194 related articles for article (PubMed ID: 31441704)
1. ZTW-41, a Potent Indolizinoquinoline-5,12-Dione Derivative Against Drug-Resistant
Lai CF; Xiao WB; Yan HC; Yang H; Wang LX; Guan H; Peng QJ; Deng ZR; Chen JW; An LK; Shi L
Microb Drug Resist; 2020 Feb; 26(2):100-109. PubMed ID: 31441704
[TBL] [Abstract][Full Text] [Related]
2. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3-ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant staphylococci.
Deshpande LM; Jones RN
Clin Microbiol Infect; 2003 Nov; 9(11):1120-4. PubMed ID: 14616730
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
7. In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus.
Kang SL; Rybak MJ
J Antimicrob Chemother; 1997 May; 39 Suppl A():33-9. PubMed ID: 9511060
[TBL] [Abstract][Full Text] [Related]
8. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
Hwang SH; Kim MN; Pai CH; Huh DH; Shin WS
Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
[TBL] [Abstract][Full Text] [Related]
9. Selenium Nanoparticles as Candidates for Antibacterial Substitutes and Supplements against Multidrug-Resistant Bacteria.
Han HW; Patel KD; Kwak JH; Jun SK; Jang TS; Lee SH; Knowles JC; Kim HW; Lee HH; Lee JH
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356651
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the efficacy of some disinfectants against nosocomial Staphylococcus aureus and Enterococcus spp. isolates].
Eryılmaz M; Akın A; Arıkan Akan O
Mikrobiyol Bul; 2011 Jul; 45(3):454-60. PubMed ID: 21935778
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and risk factors of methicillin-resistant
Huang L; Zhang R; Hu Y; Zhou H; Cao J; Lv H; Chen S; Ding S; Chen G
Antimicrob Resist Infect Control; 2019; 8():90. PubMed ID: 31164979
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antibacterial activities of omadacycline, a novel aminomethylcycline.
Macone AB; Caruso BK; Leahy RG; Donatelli J; Weir S; Draper MP; Tanaka SK; Levy SB
Antimicrob Agents Chemother; 2014; 58(2):1127-35. PubMed ID: 24295985
[TBL] [Abstract][Full Text] [Related]
14. Activity of Debio1452, a FabI inhibitor with potent activity against Staphylococcus aureus and coagulase-negative Staphylococcus spp., including multidrug-resistant strains.
Flamm RK; Rhomberg PR; Kaplan N; Jones RN; Farrell DJ
Antimicrob Agents Chemother; 2015 May; 59(5):2583-7. PubMed ID: 25691627
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic and biocide resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus.
Suller MT; Russell AD
J Hosp Infect; 1999 Dec; 43(4):281-91. PubMed ID: 10658804
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of everninomicin against clinical isolates of Enterococcus spp., Staphylococcus spp., and Streptococcus spp. tested by Etest.
Terakubo S; Takemura H; Yamamoto H; Ikejima H; Kunishima H; Kanemitsu K; Kaku M; Shimada J
J Infect Chemother; 2001 Dec; 7(4):263-6. PubMed ID: 11810596
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of meropenem/piperacillin/tazobactam triple combination therapy against clinical isolates of Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus pseudintermedius and vancomycin-resistant Enterococcus spp.
Yoneda A; Thänert R; Burnham CD; Dantas G
Int J Antimicrob Agents; 2020 Feb; 55(2):105864. PubMed ID: 31870598
[TBL] [Abstract][Full Text] [Related]
18. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic profile of daptomycin against Enterococcus species and methicillin-resistant Staphylococcus aureus in a murine thigh infection model.
Dandekar PK; Tessier PR; Williams P; Nightingale CH; Nicolau DP
J Antimicrob Chemother; 2003 Sep; 52(3):405-11. PubMed ID: 12917254
[TBL] [Abstract][Full Text] [Related]
20. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--I. Gram-positive bacteria].
Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
Jpn J Antibiot; 2003 Oct; 56(5):437-57. PubMed ID: 14692380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
